We acknowledge the relatively small size of our cohort, in particular tumours with CDKN2A/B homozygous deletion, related to IDH-mutant astrocytomas comprising a minority of all brain gliomas. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).